Evidence map›Paper›PMID 24074602›Full record

ArticleVirology2013

HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus.

Sharof M Tugizov, Rossana Herrera, Peter Chin-Hong, Piri Veluppillai, Deborah Greenspan, J Michael Berry, Christopher D Pilcher, Caroline H Shiboski, Naomi Jay, Mary Rubin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Clinical Predictors and Outcomes of Invasive Anal Cancer for People With HIV in an Inception Cohort.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  12. Review
  13. Impact of HIV on HPV-related cancers in men who have sex with men: a review.Frontiers in cellular and infection microbiology · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Sharof M TugizovDepartment of Medicine, University of California San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0512, USA; Department of Orofacial Sciences, University of California San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0512, USA. Electronic address: sharof.tugizov@ucsf.edu.
Rossana Herrera
Peter Chin-Hong
Piri Veluppillai
Deborah Greenspan
J Michael Berry
Christopher D Pilcher
Caroline H Shiboski
Naomi Jay
Mary Rubin
Aung Chein
Joel M Palefsky
University of California, San Francisco · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kate Taylor Shumate · 1999 to 2026
$209.7M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
University of Southern CaliforniaU01CA121947 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MITSUYASU, RONALD T. · 2006 to 2014
$54.7M
Molecular mechanisms of oral HIV transmission modeling MTCTR01DE023315 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TUGIZOV, SHAROF M · 2013 to 2017
$2.3M
HIV transcellular and transsynaptic penetration of mucosal epitheliumR21DE021011 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TUGIZOV, SHAROF M · 2010 to 2011
$423k
HIV AND EBV INTERACTION IN ORAL MUCOSAL EPITHELIUMR21DE016009 · NIDCR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI TUGIZOV, SHAROF M · 2004 to 2005
$417k
NCI NIH HHS P30 CA082103NCI NIH HHS P30 CA82103-13NCI NIH HHS U01 CA121947NIAID NIH HHS P30 AI027763NIAID NIH HHS P30-AI027763NIAID NIH HHS U01 AI068636NIDCR NIH HHS R01 DE023315NIDCR NIH HHS R21 DE016009NIDCR NIH HHS R21 DE021011NIDCR NIH HHS R21DE021011
6 · The paper itself

Abstract

The incidence of human papillomavirus (HPV)-associated epithelial lesions is substantially higher in human immunodeficiency virus (HIV)-infected individuals than in HIV-uninfected individuals. The molecular mechanisms underlying the increased risk of HPV infection in HIV-infected individuals are poorly understood. We found that HIV proteins tat and gp120 were expressed within the oral and anal mucosal epithelial microenvironment of HIV-infected individuals. Expression of HIV proteins in the mucosal epithelium was correlated with the disruption of epithelial tight junctions (TJ). Treatment of polarized oral, cervical and anal epithelial cells, and oral tissue explants with tat and gp120 led to disruption of epithelial TJ and increased HPV pseudovirion (PsV) paracellular penetration in to the epithelium. PsV entry was observed in the basal/parabasal cells, the cells in which the HPV life cycle is initiated. Our data suggest that HIV-associated TJ disruption of mucosal epithelia may potentiate HPV infection and subsequent development of HPV-associated neoplasia.

Indexed as

Cells, CulturedEpitheliumHIV InfectionsHumansIntestinal MucosaOrgan Culture TechniquesPapillomaviridaePapillomavirus InfectionsTight JunctionsDisruption of tight junctionsHIVHPVHPV paracellular penetrationMucosal epithelium

Identifiers

PMID24074602
PMCPMC3809142
OpenAlexW1997362773

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.